 |
Julia Karow tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Julia Karow or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
IRON-II Study Uses 454 Sequencing to Investigate New Markers for Hematological Malignancies
September 12, 2012
IRON-II Study Uses 454 Sequencing to Investigate New Markers for Hematological Malignancies
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- MLL Developing RainDance, MiSeq Gene Panel for Myeloid Malignancies
August 15, 2012 / Clinical Sequencing News - Roche Achieves Sequencing on Semiconductor Platform; Automating ePCR with Japanese Partner
January 22, 2013 / In Sequence - Study Finds Roche's NGS-Based HIV Assay Comparable to TruGene; Company Expects 2014 CE-IVD Approval
January 30, 2013 / Clinical Sequencing News - Q&A: Ralph Schlapbach on Maintaining a Variety of Platforms at the Functional Genomics Center Zurich
July 24, 2012 / In Sequence - In Applied Science Restructuring, Roche Exits Microarrays, Bundles 'Sequencing Solutions,' R&D
June 12, 2012 / In Sequence